Maynard Um
-
-
-
-
-
-
-
Black Diamond Therapeutics (BDTX) PT Raised to $7 at Freedom Capital Markets
-
-
-
-
-
-
-
Guggenheim Starts Black Diamond Therapeutics (BDTX) at Buy
-
-
-
-
-
-
-
Black Diamond Therapeutics (BDTX) PT Lowered to $15 at Stifel
-
-
-
-
-
-
-
Black Diamond Therapeutics (BDTX) Announces Restructuring Plan to Focus Resources on BDTX-1535 and Extend Cash Runway
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on Black Diamond Therapeutics (BDTX)
-
-
-
-
404,886 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

